Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 25.04.2024
KION GROUP AG
Solid start in the financial year: KION increases revenue and earnings in the first quarter
Revenue up by 2.8 percent to € 2.859 billion (Q1 2023: € 2.781 billion)
Adj. EBIT improves to € 226.7 million (Q1 2023: € 156.0 million)
Adj. EBIT margin of 7.9 percent (Q1 2023: 5.6 percent)
Positive free cash flow of € 65.7 million (Q1 2023: € 104.9 m [ … ]
Thu, 25.04.2024
SFS Group Schweiz AG
SFS Group Schweiz AG
/ Key word(s): AGMEGM
SFS receives approval for all proposals at the 2024 Annual General Meeting
25.04.2024 / 06:51 CET/CEST
The shareholders approved all proposals of the Board of Directors at the 31st Annual General Meeting of the SFS Group. The General Meeting conducted its first vote on the Sust [ … ]
Thu, 25.04.2024
Holcim Group Services Ltd
Net Sales of CHF 5,586 million, up +3.4% in local currency
Over-proportional growth in recurring EBIT of +17.1% in local currency and +7.8% in Swiss franc
Profitable growth continues in 2024 with recurring EBIT margin expansion of +0.9 percentage points
Strong contribution from Solutions & Products, roofing sales up +67% in local currency
C [ … ]
Thu, 25.04.2024
SNP Schneider-Neureither & Partner SE
Corporate News
After Record Year 2023 SNP Starts with the Best First Quarter Ever
Group revenue increased by 15% to €54.0 million in Q1 2024 (Q1 2023: €47.1 million)
EBIT rose by 63% to €4.0 million (Q1 2023: €2.5 million), EBIT margin to 7.4% (Q1 2023: 5.2%)
Operating cashflow turned significantly positive, totaling to €10.3 million (Q1 2023: [ … ]
Thu, 25.04.2024
Redcare Pharmacy N.V.
Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.
Group sales of EUR 560M in Q1, up 51% from prior year.
Non-Rx sales growth 20% to EUR 404M; Rx sales up 7% in Germany, following additional marketing and communication campaigns.
Adj. EBITDA ma [ … ]
Thu, 25.04.2024
Bucher Industries AG
Bucher Industries AG
/ Key word(s): Quarterly / Interim Statement
Sales below the prior-year period with weaker market momentum, as expected 25.04.2024 / 06:00 CET/CEST
As expected, Bucher Industries' markets weakened over the course of the first quarter of 2024 in line with the general economic slowdown. The agricultural mac [ … ]
Wed, 24.04.2024
Endor AG
Endor AG: After extending the bridging loans until June 30, 2024, the investor process for financial restructuring was initiated
Landshut, April 24, 2024 – After extending the bridging loans until June 30, 2024, the Executive Board of Endor AG initiated a recapitalization process in coordination with the financing banks. Endor AG is in ongoing dis [ … ]
Wed, 24.04.2024
Highlight Event and Entertainment AG
Ad hoc announcement pursuant to Art. 53 LR
Pratteln, April 24, 2024
Annual Report 2023
HLEE Group with stable result in 2023 financial year
Consolidated sales were CHF 421.4 million (previous year: CHF 524.0 million) due to production-related factors in the Film segment
EBIT amounted to CHF -3.5 million due to foreign currency effects (previ [ … ]
Wed, 24.04.2024
EEII AG
Ad-Hoc announcement pursuant to Art. 53 Listing Rules: Sale of Gazprom Shares
Zug, April 24, 2024
EEII AG has sold its last remaining asset from its “Eastern European” era
On April 19, 2024, EEII sold its complete holdings of 1,485,600 PJSC Gazprom (GAZP) shares to Gehold SA, Zug, at a sales price corresponding to the net asset value [ … ]
Wed, 24.04.2024
MorphoSys AG
Media Release
Planegg/Munich, Germany, April 24, 2024
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
Additional ASCO 2024 poster presentation will include new findings from the Phase 2 study of tulmimetostat
MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced th [ … ]